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Seizures are bursts of excessive synchronized
neuronal activity, suggesting that mechanisms con-
trolling brain excitability are compromised. The
voltage-gated potassium channel Kv4.2, a major
mediator of hyperpolarizing A-type currents in the
brain, is a crucial regulator of neuronal excitability.
Kv4.2 expression levels are reduced following sei-
zures and in epilepsy, but the underlyingmechanisms
remain unclear. Here, we report that Kv4.2 mRNA is
recruited to the RNA-induced silencing complex
shortly after status epilepticus inmice and after kainic
acid treatment of hippocampal neurons, coincident
with reduction of Kv4.2 protein. We show that the
microRNA miR-324-5p inhibits Kv4.2 protein expres-
sion and that antagonizing miR-324-5p is neuropro-
tective and seizure suppressive. MiR-324-5p inhibi-
tion also blocks kainic-acid-induced reduction of
Kv4.2 protein in vitro and in vivo and delays kainic-
acid-induced seizure onset in wild-type but not in
Kcnd2 knockout mice. These results reveal an impor-
tant role for miR-324-5p-mediated silencing of Kv4.2
in seizure onset.
INTRODUCTION
Seizures are episodes of synchronized brain activity, but the un-
derlying molecular mechanisms are not fully understood. The
voltage-gated potassium channel Kv4.2 (KCND2; potassium
channel, voltage-gated Shal-related subfamily D, member 2) is
a major mediator of transient A-type currents in the brain and
is important for controlling neuronal excitability (Jerng et al.,
2004). Knockout of Kv4.2 or its auxiliary subunits DPP6 (Dipep-
tidyl-peptidase-like protein 6) and KChIP2 (K channel-interactingCe
This is an open access article under the CC BY-Nprotein 2) in mice reduces A-type currents, increases dendritic
excitability and enhances susceptibility to provoked seizures
(Chen et al., 2006; Barnwell et al., 2009; Sun et al., 2011; Wang
et al., 2013). Mutations in KCND2 have been found in humans
with epilepsy (Singh et al., 2006; Lee et al., 2014) further suggest-
ing that compromised Kv4.2 function increases the brain’s
vulnerability to develop seizures.
Reduced expression and impaired function of Kv4.2 were
observed in at least three different rodent models of acquired
epilepsy (pilocarpine-induced temporal lobe epilepsy, trau-
matic brain injury and ischemic insult) (Monaghan et al., 2008;
Lei et al., 2012, 2014; Bernard et al., 2004) and in rats acutely
following evoked seizure (Francis et al., 1997; Tsaur et al.,
1992). Reduction of Kv4.2 expressionmay thus be a pathological
mechanism contributing to seizures and epilepsy; however,
the molecular mechanisms regulating Kv4.2 expression
during neuronal hyperactivity are unknown, and it is not clear
whether downregulation of Kv4.2 expression contributes to
seizure onset.
MicroRNAs recognize and bind specific sequences on their
target mRNAs via the RNA-induced silencing complex (RISC)
followed by RNA degradation or translational suppression
(Pasquinelli, 2012). Several recent studies have demonstrated
that seizures in rodents cause differential expression of micro-
RNAs, and selectmicroRNAswere shown tobe involved inmodu-
lating seizure susceptibility and epilepsy-induced neuroinflam-
mation (e.g., Brennan et al., 2016; reviewed in Reschke and
Henshall, 2015). The underlying molecular mechanisms and the
targetedmRNAs that are regulatedbymicroRNAsduring seizures
are not well established. In particular, it is not known whether
microRNA-mediated silencing of the potassium channel Kv4.2,
a crucial regulator of neuronal excitability, plays a role in the
reduction of Kv4.2 expression in epileptic mice or after status
epilepticus.
This study reveals microRNA-mediated silencing as a mecha-
nism promoting downregulation of Kv4.2 protein expression
following status epilepticus. We demonstrate that the microRNAll Reports 17, 37–45, September 27, 2016 ª 2016 The Authors. 37
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Kv4.2 mRNA Is Regulated by the
RNA-Induced Silencing Complex during
Seizure
(A and B) Kv4.2-specific qRT-PCRs of mRNA iso-
lated from immunoprecipitations (IPs) with an
Ago2-specific antibody using hippocampal tissue
(A) and cultured hippocampal neurons (B) from
mice show enrichment of Kv4.2 mRNA in Ago2 IPs
compared to IgG (paired t tests, A: *p = 0.037; B,
*p = 0.002). See Figure S1A for western blots
confirming Ago2 IP.
(C and D) Kv4.2 mRNA association with Ago2 in
hippocampus is increased 30 min after onset of
seizure (SZR) induced by i.p. injection of kainic
acid (C, paired t test, *p = 0.0005), and 4 hr
following neurotoxicity-inducing kainic acid treat-
ment in cultured hippocampal neurons (KAI) (D,
10 mM kainic acid, paired t test, *p = 0.034).
(E–H) Seizures or excitotoxicity do not affect total
Kv4.2 mRNA levels (E and F) but lead to signifi-
cantly reduced Kv4.2 protein levels (G and H)
(conditions as above, paired t tests, E, p = 0.545; F,
p = 0.375; G, *p = 0.006; H,*p = 0.021). Kv4.2
protein was still reduced in the hippocampus 3 hr
after onset of status epilepticus (Figure S1B). N
indicated in the figure; error bars represent SEM.miR-324-5p reduces Kv4.2 protein expression and further show
that antagonizing miR-324-5p is seizure suppressive, which is
mediated partially through Kv4.2. Our work provides insight
into how Kv4.2 is downregulated after seizures and highlights
the potency of a microRNA targeting an ion channel to regulate
the onset of provoked seizures.
RESULTS
Kv4.2 mRNA Is Recruited to the RISC during Neuronal
Hyperactivity
To investigate whether microRNA-induced silencing regulates
Kv4.2 expression in the brain, we quantified Kv4.2 mRNA in
Ago2-specific immunoprecipitates (IPs) from brain tissue and
neurons. Ago2 is an essential component of the RNA-induced
silencing complex (RISC) that associates with mRNAs prone to
microRNA-mediated silencing (Bartel, 2009). Using quantitative
real-time PCR, we detected enrichment of Kv4.2 mRNA in
Ago2-IPs from mouse hippocampal lysates (Figure 1A) and
cultured mouse hippocampal neurons (Figure 1B) compared to
IPs with normal mouse immunoglobulin G (IgG) (western blots
confirming Ago2 IP shown in Figure S1A). To analyze whether
the RISC is involved in the regulation of Kv4.2 expression during
seizures and excitotoxicity-inducing neuronal hyperactivity, we
quantified the association of Kv4.2 mRNA with Ago2 30 min
following onset of kainic-acid-induced status epilepticus in
mice as well as 4 hr following kainic acid exposure of cultured
hippocampal neurons in vitro. Onset of status epilepticus was
defined behaviorally according to the Racine scale. Kainic-
acid-induced neuronal hyperactivity increased the association
of Kv4.2 mRNA with Ago2 in hippocampus and cultured hippo-
campal neurons (Figures 1C and 1D), whereas total Kv4.238 Cell Reports 17, 37–45, September 27, 2016mRNA levels were unchanged (Figures 1E and 1F). Both treat-
ments also led to reduced Kv4.2 protein levels (Figures 1G and
1H). A similar reduction of Kv4.2 protein was observed 30 min
and 3 hr after onset of pilocarpine-induced status epilepticus
(Figure S1B).
MiR-324-5p Is a Specific Suppressor of Kv4.2 Protein
Expression
Usingonlinesoftware tools (microRNA.org,TargetScan),we iden-
tified miR-324-5p as a putative candidate microRNA targeting
Kv4.2 mRNA with a highly complementary seed region found in
mouse, rat, and human (Figure 2A). To assess whether miR-
324-5p regulates Kv4.2 expression, we generated a luciferase
reporter construct containing the rat Kv4.2 30UTR. Luciferase as-
says in Neuro2A (N2A) cells showed that miR-324-5p negatively
regulates Kv4.2 reporter expression (Figures 2B–2E). Co-expres-
sion of the reporter construct with pre-miR-324-5p reduced
luciferase activity (Figure 2B), and treatment of the cells with a
locked-nucleic acid (LNA)-modified ‘‘antagomir’’ containing the
miR-324-5p antisense sequence increased luciferase activity of
the reporter (Figure 2C). A reporter construct bearing a double
point mutation in the seed region-targeted sequence of the
Kv4.2 30UTR was not affected by overexpression of pre-miR-
324-5p (Figure 2D) and had increased basal luciferase activity
compared to the wild-type sequence, presumably due to of
lack of inhibition by endogenous miR-324-5p in N2A cells
(Figure 2E).
MiR-324-5p Regulates Endogenous Kv4.2 Protein
Levels
Next, we examined whether miR-324-5p controls endogenous
Kv4.2 protein levels in neurons. Previous reports have shown
that miR-324-5p is expressed in the rodent brain (Kim et al.,
2004; Capitano et al., 2016). Using fluorescence in situ hybridiza-
tion analyses, we confirmed expression of miR-324-5p in the
mouse cortex (data not shown) and showed strong expression
in both somatic and dendritic areas of the hippocampus,
whereas the signal for miR-330, a previously identified somatic
microRNA (Kye et al., 2007), was confined to the cell bodies
(Figures S2A and S2B). Inhibition of miR-324-5p in cultured
cortical and hippocampal neurons using antagomirs significantly
increased endogenous Kv4.2 protein levels as quantified by
western blotting (Figures 2F and 2G). mRNA levels were not
affected (Figure S2C). In vivo, intracerebroventricular (i.c.v.) in-
jection of a miR-324-5p-specific antagomir in mice resulted in
significant upregulation of Kv4.2 protein in the cortex and hippo-
campus after 24 hr (Figures 2H and 2I), but mRNA levels were
unchanged (Figures S2D and S2E). Reduction of miR-324-5p
by the antagomir was confirmed by qRT-PCR (Figure S2F).
Virus-mediated overexpression of pre-miR-324-5p significantly
reduced Kv4.2 protein in cortical neurons (Figure 2J) but did
not change Kv4.2 mRNA levels (Figure S2G).
Kv4.2 is a transmembrane protein that mediates potassium
currents across the plasma membrane. Using surface bio-
tinylation and western blot analyses in cultured cortical neurons
(Figure 2K), as well as non-permeabilizing fluorescence immuno-
cytochemistry in hippocampal neurons (Figure 2L), we detected
significantly reduced Kv4.2 cell-surface expression following
miR-324-5p overexpression. By contrast, GluN1 cell-surface
expression was not affected (western blot in Figure 2K, quantifi-
cation in Figure S2H). Non-permeabilizing fluorescence immu-
nocytochemistry was validated by analyzing Kv4.2 cell-surface
levels after kainic acid treatment, which showed a significant
reduction (Figure S2I). Previous studies reported that Kv4.2
mRNA translation is regulated by the Fragile X Mental Retarda-
tion Protein (FMRP) (Gross et al., 2011; Lee et al., 2011). Using
hippocampal Fmr1 knockout (KO) neurons, we showed that
FMRP is not necessary for miR-324-5p-mediated regulation of
Kv4.2 (Figure S2J).
Antagonizing miR-324-5p Delays Seizure Onset,
Reduces EEG Total Power, and Prevents Cell Death
after Intra-amygdala Kainic Acid Injection
We next tested whether miR-324-5p is affected by seizures. To-
tal hippocampal miR-324-5p levels were unchanged 30min after
onset of status epilepticus induced by intraperitoneal (i.p.) injec-
tion of kainic acid (Figure 3A), but association ofmiR-324-5pwith
the RISC component Ago2 was increased (Figure 3B). To test
whether inhibition of miR-324-5p affects seizures, we induced
status epilepticus by intra-amygdala injection of kainic acid (Ji-
menez-Mateos et al., 2012) in mice that had received scrambled
or miR-324-5p-specific antagomirs by i.c.v. injection 24 hr prior
to seizure induction (timeline shown in Figure S3A). Antagonizing
miR-324-5p significantly delayed seizure onset (Figure 3C) and
also reduced the EEG total power compared to scrambled con-
trol (Figures 3D–3F and S3B–S3F). Fluoro-Jade B (FJB) staining
72 hr after status epilepticus showed a neuroprotective effect of
anti-miR-324-5p in the hippocampus, resulting in less neuronal
death (Figures 3G and S3G–S3I). The neuroprotective effect of
miR-324-5p inhibition was confirmed in vitro in cultured hippo-campal neurons: kainic acid treatment (10 mM, 4 hr) induced
cell death in neurons transfected with control antagomir but
not in neurons transfected with miR-324-5p-specific antagomirs
(Figures 3H and 3I).
Antagonizing miR-324-5p Prevents Kainic-Acid-
Induced Downregulation of Kv4.2 and Delays Seizure
Onset in Wild-Type but Not in Kcnd2 KO Mice
We next analyzed whether miR-324-5p-specific antagomirs
blocked Kv4.2 reduction following kainic-acid-induced excito-
toxicity in vitro or status epilepticus in vivo. Kainic acid treatment
significantly reduced Kv4.2 protein expression in cultured hippo-
campal neurons transfected with control antagomirs (Figure 4A)
but not in neurons that were transfected with miR-324-5p-spe-
cific antagomirs (Figure 4B). Similarly, in vivo, seizures evoked
by i.p. injection of kainic acid reduced hippocampal Kv4.2
expression in mice that had received i.c.v. injections of scram-
bled antagomirs but not in mice that had received miR-324-5p-
specific antagomirs 24 hr prior seizure induction (Figure 4C).
MiR-324-5p was experimentally confirmed to silence a few
genes and is predicted to targetmany others (HumanTargetScan
7.1, Agarwal et al., 2015; Table S1). To assess the specific
impact of Kv4.2 on the miR-324-5p-mediated seizure-suppress-
ing effects, we tested whether blocking miR-324-5p affects
seizure onset in the absence of Kv4.2. We induced status epilep-
ticus by i.p. kainic acid injection in wild-type and Kcnd2 KOmice
(Guo et al., 2005) and assessed seizure onset using cortical EEG
recordings. As with the amygdala model of status epilepticus
(Figure 3C), antagonizing miR-324-5p prolonged the latency to
seizure onset in wild-type mice (Figure 4D). This effect was abol-
ished in Kcnd2 KO mice (Figure 4E). In contrast to a previous
study (Barnwell et al., 2009), we did not detect differences in
the latency to seizure onset between wild-type and Kcnd2 KO
mice (Figures 4D and 4E). This may be caused by different doses
of kainic acid and genetic backgrounds used, which were shown
to affect the phenotype (Barnwell et al., 2009). However, like
Barnwell and colleagues, we observed an increased seizure-
induced mortality rate (50% Kcnd2 KO mice versus 22% wild-
type mice, scrambled antagomir-injected, Figure S4A). More-
over, EEG total powerwas higher inKcnd2KOmice (Figure S4B).
Notably, the miR-324-5p-specific antagomir reduced EEG
total power regardless of genotype, although statistical signifi-
cance was not reached (Figure S4B). This suggests that, in
contrast to regulation of latency to seizure onset, other miR-
324-5p targets, apart from Kv4.2, might contribute to the effect
of miR-324-5p inhibition on EEG total power.
DISCUSSION
Reduced expression and function of the voltage-gated potas-
sium channel Kv4.2 have been associated with epilepsy and sei-
zures, but the molecular mechanisms leading to downregulation
of Kv4.2 following seizures are unknown. Here, we present data
supporting a model in which microRNA-induced silencing de-
creases Kv4.2 protein expression during excitotoxic events
and seizures. We identify miR-324-5p as a specific regulator of
Kv4.2 protein expression and show that miR-324-5p plays a
role in regulating seizures and neuronal excitotoxicity: blockingCell Reports 17, 37–45, September 27, 2016 39
Figure 2. MiR-324-5p Represses Recombinant and Endogenous Kv4.2 Protein Expression
(A) MiR-324-5p target region on mouse and rat Kv4.2 30UTRs, seed region is shown in green. Two nucleotides differ in the mouse and rat 30UTRs (highlighted in
yellow) but do not affect miR-324-5p targeting. Luciferase constructs were based on the rat sequence.
(B andC) Neuro2a cells were transfected with Kv4.2 firefly luciferase 30UTR reporters and pre-microRNA expressing plasmids (B) or antagomirs (C) (paired t tests,
B, *p = 0.0015; C, *p = 0.0012).
(D and E) Mutating two nucleotides in the seed region of the Kv4.2 30UTR (shown on top, mutated nucleotides in red) abolishes the inhibitory effect of miR-324-5p
overexpression (D), paired t test, p = 0.005), and increases luciferase activity compared to the wild-type reporter (E), paired t test, *p < 0.0001). Luciferase activity
was normalized to co-transfected Renilla firefly; pre-microRNA or antagomir sequences with no known homology served as control (NEG).
(F–L)MiR-324-5p inhibition with a sequence-specific antagomir increases endogenous Kv4.2 protein expression as analyzed bywestern blots in cultured cortical
(F) and hippocampal (G) neurons, and in cortical (H) and hippocampal (I) tissue of mice i.c.v. injected with anti-miR-324-5p or scrambled (SCR) antagomirs 24 hr
prior tissue harvest (paired t tests, F, *p = 0.048; G, *p = 0.025; unpaired t tests, H, *p = 0.05; I, *p = 0.025). MiR-324-5p overexpression using pre-microRNA-
expressing lentiviral particles reduces Kv4.2 total (J, paired t test, *p = 0.019), and cell-surface expression in cultured cortical neurons (K, paired t test, *p = 0.0007,
n indicates separate IPs from six independent experiments from three cultures), as well as cell-surface expression in cultured hippocampal neurons (L, Mann-
Whitney U test, *p = 0.0027, n represents individual neurons from three cultures). Cell-surface expression was measured using surface biotinylation and western
blot analysis in (K), and using quantitative immunofluorescence under non-permeabilizing conditions in transfected cultured hippocampal neurons in (L).
Neurons in (L) were identified by GFP co-expressed by the pre-miRNA plasmid and by morphology. Primary and secondary dendritic segments (15–50 mm), 60–
100 mm apart from the cell body, were analyzed. Examples of analyzed dendritic segments are shown in the magnifications on the bottom (white box). Scale bar,
25 mm in the overview images and 10 mm in the inset. Imageswere deconvolved andmaximum intensity projections of ten stacks (15 mm total) are shown. Contrast
(legend continued on next page)
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Figure 3. Inhibition of miR-324-5p Reduces Kainic-Acid-Induced Seizure Severity and Excitotoxicity
(A and B) Total miR-324-5p levels are unchanged 30min following seizure onset induced by i.p. injection of kainic acid (A, paired t test, p = 0.908), but association
of miR-324-5p with Ago2 is increased (B, paired t test, *p = 0.030).
(C–F) i.c.v. injections of miR-324-5p antagomirs delayed seizure onset following intra-amygdala kainic acid injection (C, independent t test, *p = 0.048) and
reduced total EEG power 40min post kainic acid (D, independent t test, *p = 0.010) and 60min post lorazepam (E, independent t test, *p = 0.032). Lorazepamwas
used to end the seizures. Example EEGs are shown in (F); additional analyses and timeline of the experiment are shown in Figures S3A–S3F.
(G) Antagonizing miR-324-5p reduces seizure-induced cell death in the dorsal hippocampus as shown by Fluoro-Jade B staining (independent t test, *p = 0.025).
Similar results were obtained for ventral hippocampus, CA1, and CA3 subfields (Figures S3G–S3I).
(H and I) Propidium iodide staining in living hippocampal neurons (14 days in vitro) shows reduced kainic-acid-induced cell death in neurons transfectedwithmiR-
324-5p antagomirs compared to control antagomirs. Neurons were analyzed 4 hr following treatment with 10 mM kainic acid, and DAPI staining was used as a
counterstain. Scale bar, 200 mm. Contrasts were adjusted equally for all example images in (H). Shown in (I) is the relative increase in propidium iodide-positive
cells normalized to control (Kruskal-Wallis test p = 0.036; Dunn’s post hoc tests *p = 0.036; n.s.p > 0.9999). N indicated in the figure; error bars represent SEM.miR-324-5p prevents kainic-acid-mediated reduction of Kv4.2
protein, delays kainic-acid-induced seizure onset, decreases
EEG total power after kainic acid treatment, and is neuroprotec-
tive. MiR-324-5p inhibition does not delay seizure onset in mice
that lack Kv4.2, supporting an important role of Kv4.2 in medi-
ating the seizure-delaying effect of miR-324-5p.was adjusted equally for both images. Quantification of GluN1 surface expressio
(Figure S2H). Mir-324-5p expression patterns in the mouse brain are shown in Fi
antagomir or by overexpressing pre-miR-324-5p (Figures S2C–S2E and S2G). Cu
error bars are SEM.Previous studies have detected reduced expression of Kv4.2
mRNA and protein in the hippocampus several hours following
seizures (Francis et al., 1997; Tsaur et al., 1992). In this study,
we analyzed early events regulating Kv4.2 expression shortly
after seizure and demonstrate that Kv4.2 mRNA is recruited to
the RISC 30 min after kainic-acid-induced status epilepticusn in biotinylation experiments shown in (K) revealed no significant differences
gures S2A and S2B. Kv4.2 mRNA levels were not affected by the miR-324-5p
ltured neurons were between 11 and 15 days in vitro. N indicated in the figure;
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Figure 4. Kv4.2 Contributes to the Seizure-Suppressing Effect of
miR-324-5p Inhibition
(A and B) Antagonizing miR-324-5p prevents kainic-acid-induced reduction
of Kv4.2 protein levels in cultured neurons (paired t tests; A, negative control:
*p = 0.011; B, anti-miR324-5p: p = 0.324). Antagomirs were expressed for less
than 24 hr.
(C) i.c.v. injection of miR-324-5p antagomirs prevents reduction in Kv4.2
expression in the hippocampus 1 hr after kainic-acid-induced seizure (two-
way ANOVA; effect of antagomir *p = 0.0002, effect of seizure p = 0.198;
interaction p = 0.145; Sidak’s post hoc tests (ctr-seizure): scrambled,
p = 0.110; miR-324-5p: p = 0.99).
(D and E) i.c.v. injection of miR-324-5p antagomirs delays seizure onset after
i.p. injection of kainic acid in wild-type (D, independent t test, *p = 0.013), but
not in Kcnd2 KO mice (E, independent t test, p = 0.84). Seizure onset was
determined by cortical EEG recordings. Mortality rates and EEG power ana-
lyses are shown in Figure S4. Seizures were terminated after 90 min by i.p.
injection of diazepam. N indicated in the figure; error bars represent SEM.(Figure 1C), suggesting that increased microRNA-induced
silencing of Kv4.2 contributes to Kv4.2 protein downregulation
in the hippocampus (Figure 1G). In line with this hypothesis, inhi-
bition of miR-324-5p, a microRNA that we show suppresses
Kv4.2 protein expression in the brain (Figures 2F–2L), coun-
teracts kainic-acid-induced downregulation of Kv4.2 protein42 Cell Reports 17, 37–45, September 27, 2016(Figures 4A–4C). Two other microRNAs, miR-223-3p and miR-
301a-3p, were shown to regulate Kv4.2 in the heart (Panguluri
et al., 2013; Liu et al., 2016), but their function in neurons and dur-
ing seizures is unknown.
We did not detect changes in total miR-324-5p levels shortly
after seizure (Figure 3A). A previous study identified miR-324-
5p as one of several microRNAs that were downregulated in
the hippocampus 24 hr following pilocarpine-induced status
epilepticus (Kretschmann et al., 2015), but this result was not re-
produced in a similar study using kainic acid to induce seizures
(Jimenez-Mateos et al., 2011). Another study showed hippocam-
pal upregulation of miR-324-5p in a rat epilepsy model 60 days
following lithium-pilocarpine-induced status epilepticus (Song
et al., 2011). In the future, it will be interesting to analyze whether
miR-324-5p and Kv4.2 expression are co-regulated at later time
points after status epilepticus. We show that miR-324-5p is re-
cruited to the RISC 30 min after seizure (Figure 3B), suggesting
early dynamic changes in the composition of miRISC during
neuronal hyperexcitation. These findings add to recent discov-
eries that microRNA association with the RISC is not static, but
dynamic changes remodeling RISC can occur in response to
synaptic activity (Muddashetty et al., 2011; Jimenez-Mateos
et al., 2012).
A prerequisite for our observation that changes in microRNA-
induced translational silencing have an immediate impact on
Kv4.2 protein expression (within 30 min to 4 hr, Figures 1G,
1H, and 4A–4C) is that the turnover rate of Kv4.2 protein must
be fast. A study in COS-1 cells using recombinant Kv4.2 protein
has shown that the half-life of Kv4.2 is indeed relatively short,
namely 2 hr (Shibata et al., 2003). In cultured neurons, Kv4.2
protein is rapidly degraded within minutes in response to gluta-
matergic activation (Lee et al., 2011). Thus, under physiological
conditions in the brain the turnover rate of Kv4.2 might be even
faster than 2 hr. We speculate that the reduction in Kv4.2 evident
30 min after seizure is a combination of increased Kv4.2 degra-
dation and reduced Kv4.2 synthesis. Nonetheless, blockingmiR-
324-5p-mediated translational suppression of Kv4.2 abolishes
kainic-acid-induced Kv4.2 reduction (Figures 4A–4C), implying
that increased Kv4.2 protein synthesis can overcome excitotox-
icity-induced Kv4.2 degradation.
It was previously shown that Kv4.2 mRNA is translationally
regulated by the mRNA-binding protein FMRP (Lee et al.,
2011; Gross et al., 2011). The exact mechanisms and conse-
quences of loss of FMRP on Kv4.2 expression and function
remain controversial, as both decreased and increased levels
and function of Kv4.2 have been shown in Fmr1 KO mice (Kalm-
bach et al., 2015; Gross et al., 2011; Lee et al., 2011; Routh et al.,
2013). FMRP interacts with the microRNA pathway (Jin et al.,
2004) and cooperates with microRNAs to regulate translation
of certain mRNA targets (Muddashetty et al., 2011; Edbauer
et al., 2010). Our results suggest that FMRP is not necessary
for the gene silencing effects of miR-324-5p on Kv4.2 (Fig-
ure S2J), but future studies are needed to investigate the rela-
tionship between FMRP- and microRNA-mediated translational
control of Kv4.2 and its significance for seizure-induced downre-
gulation of Kv4.2.
Manipulation of miR-324-5p is expected to affect multiple
mRNA targets in addition to Kv4.2, since microRNAs usually
regulate numerous mRNAs. Our results in Kcnd2 KO mice show
that a miR-324-5p-specific antagomir does not delay seizure
onset in the absence of Kv4.2 and thus support a specific role
of Kv4.2 in the delay in seizure onset mediated by miR-324-5p
inhibition. However, our analyses also suggest that Kv4.2 is
dispensable for the effects of miR-324-5p inhibition on EEG total
power (Figure S4B), and it is unclear whether the observed neu-
roprotective effect (Figures 3G–3I) is mediated through Kv4.2.
There are a few experimentally confirmed targets of miR-324-
5p that might be involved in neuroprotection after miR-324-5p
inhibition, and other potassium channels are predicted to be
targets that may contribute to seizure suppression (Table S1).
In the future, it will be interesting to assess the contribution
of individual targets of miR-324-5p to the neuroprotective and
seizure-suppressing effects of miR-324-5p inhibition.
EXPERIMENTAL PROCEDURES
Mice and Materials
For a list of mice, antibodies, drugs, and source and sequence of antago-
mirs, FISH probes, and qRT-PCR primers, see Supplemental Experimental
Procedures.
Ago2 Co-immunoprecipitation
Ago2 co-IPs were done using a mouse monoclonal Ago 2 antibody and
Protein-G-coupled agarose. For details, see Supplemental Experimental
Procedures.
RNA Isolation and qRT-PCR
RNA was extracted using Trizol (Life Technologies), followed by cDNA prepa-
ration and qRT-PCR analysis using SYBR green or TaqMan assays. For de-
tails, see Supplemental Experimental Procedures.
Luciferase Assays
Luciferase assays were carried out using the Dual-Glo Luciferase Assay Sys-
tem (Promega) and a Luminometer (Veritas, Promega). For details, see Supple-
mental Experimental Procedures.
Fluorescence In Situ Hybridization
Fluorescence in situ hybridization on mouse brain slices was performed as
described in Muddashetty et al. (2011). For details, see Supplemental Exper-
imental Procedures.
Intracerebroventricular Injection of MicroRNAs
For i.c.v. injections of miR-324-5p-specific or scrambled antagomirs, mice
received a 2-ml infusion of 0.5 nmol of either scrambled ormiR-324-5p-specific
antagomirs in artificial cerebrospinal fluid (aCSF). For experiments shown in
Figures 3C–3G, a cannula was implanted for kainic acid injection at the time
of antagomir injection. Mice were euthanized to quantify miR-324-5p or
Kv4.2 protein and mRNA after 24 hr. Alternatively, status epilepticus was
induced after 24 hr by i.p. or intra-amygdala kainic acid injection.
Seizure Models
For experiments shown in Figures 1C, 1E, 1G, 3A, 3B, 4C–4E, and S4, seizures
were induced in male C57BL/6 mice or male Kcnd2 KOmice in C57BL/6 back-
ground (Figures 4E and S4) by i.p. injection of kainic acid (15 mg/kg). Control
mice received PBS injections. For experiments in Figures 1C, 1E, 1G, 3A, and
3B, mice were between postnatal days 24 and 28 and were euthanized 30 min
after behavioral seizure onset. In Figures 4C–4E, mice were between 6 and
9 weeks old (20–23 g). In Figure 4C, mice were euthanized 90 min after injec-
tion of kainic acid. Behavioral seizure onset was defined as a full tonic-clonic
seizure. In Figures 4D and 4E, seizure onset was identified by cortical EEG re-
cordings using a wireless EEG system (TA11ETAF10) from Data Sciences In-
ternational. A seizure was defined as sudden onset of high amplitude activity(>23 background) and a duration greater than 10 s. Seizures were terminated
by subcutaneous injection of diazepam 90 min after seizure onset (10 mg/kg).
Experiments shown in Figures 3C–3F and S3 were done as described (Jime-
nez-Mateos et al., 2012). Also, see Supplemental Experimental Procedures.
Surface Biotinylation
Cultured Cortical neurons at 12 days in vitro were transduced with lentiviral
particles expressing pre-miR-324-5p or control sequence. After 5–6 days,
surface biotinylation was performed as in Gross et al. (2011). For details, see
Supplemental Experimental Procedures.
Fluorescence Immunocytochemistry
For fluorescence immunocytochemistry under non-permeabilizing conditions,
neurons between days 10 and 12 in vitro were transfected with plasmids ex-
pressing GFP and pre-miR-324-5p or a control sequence using Lipofectamine
2000 (Invitrogen). After 24 hr, neurons were stained for Kv4.2 without deter-
gents. Cells were imaged using a Nikon Eclipse Ti inverted microscope. Hip-
pocampal pyramidal neurons were identified according to their morphology.
Images were deconvolved using AutoQuant X2 (Media Cybernetics) or NIS
Elements (Nikon), and fluorescence intensities in primary and secondary den-
dritic segments (15–50 mm in length, 15-mm stack), 60–100 mm apart from
the cell body, were quantified using ImageJ (NIH). For details (including image
processing), see Supplemental Experimental Procedures.
Propidium Iodide Staining
Propidium iodide staining was performed as described inGauthier et al. (2012).
For details, see Supplemental Experimental Procedures.
Fluoro-Jade B Staining
Fluoro-Jade B staining (EMD Millipore) was performed and analyzed as
described previously (Moran et al., 2013). Mice were sacrificed 72 hr after
seizure induction. Postfixed sections were incubated in 0.006% potassium
permanganate solution, followed by 0.001% FJB solution and imaged using
a Nikon 2000s epifluorescence microscope and a Hamamatsu Orca 285
camera.
Statistical Analyses
Data were analyzed using GraphPad Prism6. Data were tested for normality
using Shapiro-Wilk tests, and appropriate parametric or non-parametric tests
were used as indicated in each figure legend. Significance level was set to a <
0.05. For two-group/two-factor analyses, two-way ANOVA with Tukey’s post
hoc assays was performed, except for Figure 3I, where a Kruskal-Wallis test
followed by Dunn’s post hoc analyses was performed, as the data were not
normally distributed. Data are expressed as means with SEM. Repetitions of
experiments are indicated in the legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.08.074.
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